自己免疫性肝疾患患者への新型コロナウイルスワクチン接種に関する情報提供による心理的影響
背景:Coronavirus disease 2019(COVID-19)に対し開発されたワクチンの有効性が報告されたが,併存症を有する症例への効果等の情報は限定的である.目的:COVID-19関連の情報提供が自己免疫性肝疾患患者のワクチン接種意識に及ぼす影響を検討した.対象・方法:自己免疫性肝疾患患者連続40症例を対象に「難治性の肝・胆道疾患に関する調査研究」班からのCOVID-19関連の公開文章がワクチン接種意識に及ぼす変化を評価した.結果:原発性胆汁性胆管炎15名,自己免疫性肝炎18名,その他7名であった.慢性肝炎34名,年齢中央値は62歳,女性33名であった.情報提供前後でワクチンを「...
Saved in:
Published in | 肝臓 Vol. 62; no. 10; pp. 613 - 619 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | Japanese |
Published |
一般社団法人 日本肝臓学会
01.10.2021
|
Subjects | |
Online Access | Get full text |
ISSN | 0451-4203 1881-3593 |
DOI | 10.2957/kanzo.62.613 |
Cover
Abstract | 背景:Coronavirus disease 2019(COVID-19)に対し開発されたワクチンの有効性が報告されたが,併存症を有する症例への効果等の情報は限定的である.目的:COVID-19関連の情報提供が自己免疫性肝疾患患者のワクチン接種意識に及ぼす影響を検討した.対象・方法:自己免疫性肝疾患患者連続40症例を対象に「難治性の肝・胆道疾患に関する調査研究」班からのCOVID-19関連の公開文章がワクチン接種意識に及ぼす変化を評価した.結果:原発性胆汁性胆管炎15名,自己免疫性肝炎18名,その他7名であった.慢性肝炎34名,年齢中央値は62歳,女性33名であった.情報提供前後でワクチンを「接種する」は23名から34名,「(とても)不安」は29名から14名になった.結語:自己免疫性肝疾患患者のワクチン接種の自己決定を情報提供により援助できた.また,ワクチン接種に対する不安も軽減できた. |
---|---|
AbstractList | 背景:Coronavirus disease 2019(COVID-19)に対し開発されたワクチンの有効性が報告されたが,併存症を有する症例への効果等の情報は限定的である.目的:COVID-19関連の情報提供が自己免疫性肝疾患患者のワクチン接種意識に及ぼす影響を検討した.対象・方法:自己免疫性肝疾患患者連続40症例を対象に「難治性の肝・胆道疾患に関する調査研究」班からのCOVID-19関連の公開文章がワクチン接種意識に及ぼす変化を評価した.結果:原発性胆汁性胆管炎15名,自己免疫性肝炎18名,その他7名であった.慢性肝炎34名,年齢中央値は62歳,女性33名であった.情報提供前後でワクチンを「接種する」は23名から34名,「(とても)不安」は29名から14名になった.結語:自己免疫性肝疾患患者のワクチン接種の自己決定を情報提供により援助できた.また,ワクチン接種に対する不安も軽減できた. |
Author | 滝川, 康裕 柿坂, 啓介 吉田, 雄一 鈴木, 悠地 |
Author_xml | – sequence: 1 fullname: 滝川, 康裕 organization: 岩手医科大学内科学講座消化器内科肝臓分野 – sequence: 1 fullname: 柿坂, 啓介 organization: 岩手医科大学内科学講座消化器内科肝臓分野 – sequence: 1 fullname: 吉田, 雄一 organization: 岩手医科大学内科学講座消化器内科肝臓分野 – sequence: 1 fullname: 鈴木, 悠地 organization: 岩手医科大学内科学講座消化器内科肝臓分野 |
BookMark | eNo9kElLw0AcxQdRsGpvfo3UWZJM5qaIGxS86DlM0kRbtUrrRU9mYlUUtaeCigvuWFyKB_Wgfpi_Seq3sC4Ij_fg9-AdXhdqL84XPYR6Cc5QYfC-GVlcns-YNGMS1oZSxLKIxgzB2lEK6wbRdIpZJ0qXy3kHY2pyLARNoaC5fhM9NaLKdlKrxytXTXWY1N5iddZSc6UCwTMEd3HtITraAvUI4S2Em6AuQZ1DWAf1AuE9qHsIAwgf452L5PoOgvpn7RSCPVBbcViJThrxbvXj7aDFQW20YPQeJtW1ZH81em18Hr_3oA5fzpa99F92o8nhoYnBUS07PjI2OJDVCpQzohmU54j0nRwxHJe5wmQm96lFXUqcnKXniG65jHuCceFj4RrUF5gLnXJXSMN0GOtG_b-7hfKinPLshVJ-TpaWbFlazLuznv3zn21Sm-Bvb734X7nTsmQXJPsCXxCaaw |
ContentType | Journal Article |
Copyright | 2021 一般社団法人 日本肝臓学会 |
Copyright_xml | – notice: 2021 一般社団法人 日本肝臓学会 |
DOI | 10.2957/kanzo.62.613 |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1881-3593 |
EndPage | 619 |
ExternalDocumentID | article_kanzo_62_10_62_613_article_char_ja |
GroupedDBID | ALMA_UNASSIGNED_HOLDINGS CS3 JSF KQ8 OK1 P2P RJT |
ID | FETCH-LOGICAL-j2731-527d1afbd15bc3c96367f282c21bd84d148c37e9379f09c52f9079427c9a56b33 |
ISSN | 0451-4203 |
IngestDate | Wed Sep 03 06:31:10 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Language | Japanese |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-j2731-527d1afbd15bc3c96367f282c21bd84d148c37e9379f09c52f9079427c9a56b33 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/kanzo/62/10/62_613/_article/-char/ja |
PageCount | 7 |
ParticipantIDs | jstage_primary_article_kanzo_62_10_62_613_article_char_ja |
PublicationCentury | 2000 |
PublicationDate | 20211000 |
PublicationDateYYYYMMDD | 2021-10-01 |
PublicationDate_xml | – month: 10 year: 2021 text: 20211000 |
PublicationDecade | 2020 |
PublicationTitle | 肝臓 |
PublicationTitleAlternate | 肝臓 |
PublicationYear | 2021 |
Publisher | 一般社団法人 日本肝臓学会 |
Publisher_xml | – name: 一般社団法人 日本肝臓学会 |
References | 11) Kakisaka K, Sakai A, Yoshida Y, et al. Hepatitis B Surface Antibody Titers at One and Two Years after Hepatitis B Virus Vaccination in Healthy Young Japanese Adults. Intern Med 2019; 58: 2349-2355 8) Dowdle WR. The principles of disease elimination and eradication. Bull World Health Organ 1998; 76 (Suppl 2): 22-25 1) Baden LR, El Sahly HM, Essink B, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med 2021; 384: 403-416 9) Aylward B, Hennessey KA, Zagaria N, et al. When is a disease eradicable? 100 years of lessons learned. Am J Public Health 2000; 90: 1515-1520 3) Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 2021; 397: 99-111 10) Castells MC, Phillips EJ. Maintaining Safety with SARS-CoV-2 Vaccines. N Engl J Med 2021; 384: 643-649 13) Rottem M, Shoenfeld Y. Vaccination and allergy. Curr Opin Otolaryngol Head Neck Surg 2004; 12: 223-231 4) Freeman D, Loe BS, Chadwick A, et al. COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychol Med 2020; 1-15 2) Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med 2020; 383: 2603-2615 14) Sakai A, Noguchi E, Fukushima T, et al. Identification of amino acids in antigen-binding site of class II HLA proteins independently associated with hepatitis B vaccine response. Vaccine 2017; 35: 703-710 15) Schwartz KL, Neale AV, Northrup J, et al. Racial similarities in response to standardized offer of influenza vaccination. A MetroNet study. J Gen Intern Med 2006; 21: 346-351 12) Nishida N, Sugiyama M, Ohashi J, et al. Importance of HBsAg recognition by HLA molecules as revealed by responsiveness to different hepatitis B vaccines. Sci Rep 2021; 11: 3703 5) Wouters OJ, Shadlen KC, Salcher-Konrad M, et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet 2021; 397: 1023-1034 7) Elkins G, Staniunas R, Rajab MH, et al. Use of a numeric visual analog anxiety scale among patients undergoing colorectal surgery. Clin Nurs Res 2004; 13: 237-244 6) Tan SS, Goonawardene N. Internet Health Information Seeking and the Patient-Physician Relationship: A Systematic Review. J Med Internet Res 2017; 19: e9 |
References_xml | – reference: 11) Kakisaka K, Sakai A, Yoshida Y, et al. Hepatitis B Surface Antibody Titers at One and Two Years after Hepatitis B Virus Vaccination in Healthy Young Japanese Adults. Intern Med 2019; 58: 2349-2355 – reference: 5) Wouters OJ, Shadlen KC, Salcher-Konrad M, et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet 2021; 397: 1023-1034 – reference: 14) Sakai A, Noguchi E, Fukushima T, et al. Identification of amino acids in antigen-binding site of class II HLA proteins independently associated with hepatitis B vaccine response. Vaccine 2017; 35: 703-710 – reference: 15) Schwartz KL, Neale AV, Northrup J, et al. Racial similarities in response to standardized offer of influenza vaccination. A MetroNet study. J Gen Intern Med 2006; 21: 346-351 – reference: 12) Nishida N, Sugiyama M, Ohashi J, et al. Importance of HBsAg recognition by HLA molecules as revealed by responsiveness to different hepatitis B vaccines. Sci Rep 2021; 11: 3703 – reference: 13) Rottem M, Shoenfeld Y. Vaccination and allergy. Curr Opin Otolaryngol Head Neck Surg 2004; 12: 223-231 – reference: 1) Baden LR, El Sahly HM, Essink B, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med 2021; 384: 403-416 – reference: 9) Aylward B, Hennessey KA, Zagaria N, et al. When is a disease eradicable? 100 years of lessons learned. Am J Public Health 2000; 90: 1515-1520 – reference: 10) Castells MC, Phillips EJ. Maintaining Safety with SARS-CoV-2 Vaccines. N Engl J Med 2021; 384: 643-649 – reference: 7) Elkins G, Staniunas R, Rajab MH, et al. Use of a numeric visual analog anxiety scale among patients undergoing colorectal surgery. Clin Nurs Res 2004; 13: 237-244 – reference: 8) Dowdle WR. The principles of disease elimination and eradication. Bull World Health Organ 1998; 76 (Suppl 2): 22-25 – reference: 2) Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med 2020; 383: 2603-2615 – reference: 6) Tan SS, Goonawardene N. Internet Health Information Seeking and the Patient-Physician Relationship: A Systematic Review. J Med Internet Res 2017; 19: e9 – reference: 3) Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 2021; 397: 99-111 – reference: 4) Freeman D, Loe BS, Chadwick A, et al. COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychol Med 2020; 1-15 |
SSID | ssib002670992 ssib000940394 ssib002670224 ssib058493441 ssj0069113 ssib005879686 ssib002484534 |
Score | 2.2786596 |
Snippet | 背景:Coronavirus disease... |
SourceID | jstage |
SourceType | Publisher |
StartPage | 613 |
SubjectTerms | COVID-19 information sharing vaccination ワクチン 情報共有 |
Title | 自己免疫性肝疾患患者への新型コロナウイルスワクチン接種に関する情報提供による心理的影響 |
URI | https://www.jstage.jst.go.jp/article/kanzo/62/10/62_613/_article/-char/ja |
Volume | 62 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | 肝臓, 2021/10/01, Vol.62(10), pp.613-619 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR3LbtQwMEJFQlwQT_FWD_i4JbETxz4mu1lVoCIhtRK3VZLdPRSpIFQunLrZFhAV0NNKgHiIt6h4VByAA-3HmN1t_4LxONmGx4GHZEUTe2Y8DzuesZzEsk4x4SVumrQqzaYHCQqPmxWRxhDIJT6LISMS7Vjvd0yd45Mz7pkL3oUdY4ulU0tX55OJ9Npv3yv5F69CHfhVvyX7F54dMYUKgMG_cAUPw_WPfEwiQSCZDwISeST0SehoQECpkcgnkpMgJBHXpxkCH5EpkUVTGGETJQErAUIjA4eIQYxJQpEDASJrKlt3ISMiQmyiJGQIMBLUckAEeVPAC8AtcEZUsqipFzj1gtzJgdAIFpHA0zIHAsUw8gAfiQrSvEbKnI8wKjPUwiOBjWaBmjqRILyrFZdhiY-hEiVyMGZdc9CGAmtwBAIiXGyqIUPovQ5o5eC-ZGH0ixw9U3X_YYgt6CgAYGjjTaDvAR-Mb_4DWuAjezR2TXPN8SUUhlqEIOo2voeSSpTU1V5CfKk11WK72pXC3saXWuPQxY6q2rSIb4aBcXEVuJT3hKgzOl1oZvGIK6oLGlTRS2hgzSDMR1aoNUPkQBdtZhupoGsffWtkqP5qP3RgDccRkFfBCaWFy9XTntrGyC2zsArhVJiXGz5feTktP2Hs0jrKHVYKybhZVX9e7anEX1RfhCTq0gSnEyOiH76fns_OBqI1OG1A2gtXQG4UTfoFx8YsZFk7qe_jYY-z50tJinRtVt4EcYXrsfImhq8D4R_uZemsgid8ybc_0ggRv2SYhJh4kUO4gedgCquZ13O0cqfLqkGIPAsJY3HYFOPf6b3WnjxxHQ-MMvusHbPxfmvXVH4054DV2bzxpv9prb90e9hbHSy82sweDnvrg-wZlM2FJdX5rDrvBr0P_UfLKvuoum9V95bKXqrsueququyL6r5X2XvV7ajux8GdF8PX71Rndav3VHXuqWx50F3qP1kb3F35tv4A6lV2Eyr7G93hyvXh_cX-17WtxxsHrZl6NF2drOT_d6nMQtLkVDzqN524nTQdL0lZCqEA99tU0JQ6SVO4TccVKfNbkEDJti1Tj7alDeED9VMZezxh7JA1NndprnXYGm8Jylt2zKjHWi5NbRk33ZilEMBQ7sROcsSSxniNy-YjPo0_HxZH_4P2mLV7e34et8bmr1xtnYAsZj45iYPsO294Elo |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%87%AA%E5%B7%B1%E5%85%8D%E7%96%AB%E6%80%A7%E8%82%9D%E7%96%BE%E6%82%A3%E6%82%A3%E8%80%85%E3%81%B8%E3%81%AE%E6%96%B0%E5%9E%8B%E3%82%B3%E3%83%AD%E3%83%8A%E3%82%A6%E3%82%A4%E3%83%AB%E3%82%B9%E3%83%AF%E3%82%AF%E3%83%81%E3%83%B3%E6%8E%A5%E7%A8%AE%E3%81%AB%E9%96%A2%E3%81%99%E3%82%8B%E6%83%85%E5%A0%B1%E6%8F%90%E4%BE%9B%E3%81%AB%E3%82%88%E3%82%8B%E5%BF%83%E7%90%86%E7%9A%84%E5%BD%B1%E9%9F%BF&rft.jtitle=%E8%82%9D%E8%87%93&rft.au=%E6%BB%9D%E5%B7%9D%2C+%E5%BA%B7%E8%A3%95&rft.au=%E6%9F%BF%E5%9D%82%2C+%E5%95%93%E4%BB%8B&rft.au=%E5%90%89%E7%94%B0%2C+%E9%9B%84%E4%B8%80&rft.au=%E9%88%B4%E6%9C%A8%2C+%E6%82%A0%E5%9C%B0&rft.date=2021-10-01&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA%E3%80%80%E6%97%A5%E6%9C%AC%E8%82%9D%E8%87%93%E5%AD%A6%E4%BC%9A&rft.issn=0451-4203&rft.eissn=1881-3593&rft.volume=62&rft.issue=10&rft.spage=613&rft.epage=619&rft_id=info:doi/10.2957%2Fkanzo.62.613&rft.externalDocID=article_kanzo_62_10_62_613_article_char_ja |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0451-4203&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0451-4203&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0451-4203&client=summon |